A new study found that fair prices for medications like Wegovy and Zepbound would be hundreds less per month than they are ...
Wegovy and Zepbound — are cutting prices to make the medications more affordable for people without insurance.
To be a person in the year 2025 is to encounter, in one way or another, the marketing onslaught for compounded ...
The end of compounded versions of weight-loss drugs is near, leaving patients scrambling for alternatives. Some “copycat” ...
The exact price depends on dosage, pharmacy, location, insurance coverage, and available savings programs. Fully understanding the various factors affecting ...
Compounded versions of popular drugs used for weight loss including Wegovy and Zepbound will soon no longer be available ...
Why some health groups are banding together to push for a range of obesity-care options in workplace-sponsored insurance.
Roller-coaster healthcare stock Hims & Hers Health ( HIMS -1.34%), whose stock got devastated last week by worries that it ...
A federal judge’s ruling restricts compounding pharmacies from producing generic Zepbound, sparking concerns over ...
How weight loss drugs actually work, and how big-name prescriptions differ from each other. What investors need to know about ...
A study in people with obesity and diabetes again found CagriSema helps people lose weight, but not by enough to clearly ...
Novo Nordisk released the results from its late-stage trial of CagriSema on Monday. It showed that patients on the highest dose of the drug lost 15.7% of their weight.
Some results have been hidden because they may be inaccessible to you
Show inaccessible results